Oct 2026· In Vivo· Vol 40, pp. 3617 - 3629· 0 citations· 36 references
Medicine
TL;DR
Dogs with CCL demonstrated increased Tregs in both peripheral blood and intratumorally, suggesting a role of these cells in CCL-associated immunomodulation, and their accumulation highlights potential therapeutic targets in veterinary oncology.
Abstract
Background/Aim: Regulatory T cells (Tregs) are immunosuppressive lymphocytes that maintain immune homeostasis but may also facilitate tumor immune evasion. Their role in canine cutaneous lymphoma (CCL) remains insufficiently understood. We hypothesized that dogs with CCL would exhibit increased Treg levels in both peripheral blood and tumor tissue, thereby contributing to local and systemic immune modulation. Our objective was to evaluate Treg levels in blood and skin of dogs with CCL compared with healthy controls. Materials and Methods: Twenty-four dogs were enrolled: 12 with T-cell cutaneous lymphoma confirmed by histopathology and immunohistochemistry and 12 clinically healthy controls, recruited from a veterinary teaching hospital population. In this prospective study, circulating Tregs were quantified by flow cytometry, and FoxP3+ cells in skin were evaluated by immunohistochemistry. Statistical analyses included t-tests, non-parametric tests, and Kaplan–Meier survival analysis. Results: Dogs with CCL had significantly higher circulating Tregs than controls (10.84±1.18% vs. 5.67±0.89%, p=0.0021). FoxP3+ cells were detected exclusively in neoplastic skin (mean, 8.27±5.71%), with no labeling in healthy skin (p=0.0007). No significant differences were observed between epitheliotropic and non-epitheliotropic subtypes. Treg levels and the Treg/CD8+ ratio were not associated with survival outcomes (p>0.20). Conclusion: Dogs with CCL demonstrated increased Tregs in both peripheral blood and intratumorally, suggesting a role of these cells in CCL-associated immunomodulation. Although Treg levels were not prognostic in this cohort, their accumulation highlights potential therapeutic targets in veterinary oncology.
Vitiligo is an autoimmune skin disorder characterized by T-cell-mediated melanocyte destruction and loss of immune tolerance. Dysregulation of regulatory T cells and altered chemokine signaling have been implicated; however, their relationship with disease activity remains unclear. Therefore, this study aimed to evalua...
Dalia T. Kamal, Wafaa T. El-Sherif, Eman R. M. Hofny et al.· Egyptian Journal of Immunolo...· 0 citations
Patients with tuberculosis exhibited weaker CD4⁺ T-cell responses and higher Treg frequencies, suggesting immune dysregulation during Mycobacterium tuberculosis infection, which may contribute to tuberculosis pathogenesis.
Mohammed J. Mohammed· Natural Resources for Human...· 0 citations
OBJECTIVE
The frontline treatment for endometrial cancer (EC) is a hysterectomy; immunotherapy is approved, but has limited efficacy in all EC genotypes (mismatch repair genotypes). Understanding how EC pathogenesis affects the immune response is essential to determine effective interventions. Systemic inflammation, dr...
Sarah Nelson, P. Diaz-Sylvester, Taylor Badger et al.· Cancer Treatment and Researc...· 0 citations
The paradox of immune resistance in High-Grade Serous Carcinoma (HGSC) of the ovary, despite high immune cell infiltration, is caused by a complex, multi-layered immunosuppressive tumor microenvironment (TME) that disables and excludes effector immune cells. This is resolved by the aggressive co-option of immunosuppres...
Regulatory T (Treg) cells play a key role in immune tolerance and homeostasis. They prevent exaggerated immune responses, autoimmunity, and are crucial in graft‐versus‐host responses. On the other hand, their presence in many tumors is associated with a poor prognosis. In aged individuals, Treg populations are modified...
L. Muller, Jana Bleher, Birgit Weinberger et al.· FEBS Open Bio· 0 citations
Attending to the functional state allows these conditions to be organized coherently and supports a therapeutic conception of Treg control that differs in direction according to the disease: weakening the function where it is enhanced, and restoring it where it is impaired.
Yu Katsuma, E. Sakai, Yoshinori Sumita· International Journal of Mol...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.